Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 21, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for October 11, 2007 Subscribe to this News Feed     Subscribe to this Podcast Feed  
 

Migraine Pill Topamax Eases Alcoholism Withdrawal Symptoms and Cravings

Anti-Craving Medications Helpful in Overcoming Alcohol Dependence

Anchorage, AK (PRWEB) October 11, 2007 -- In a study published this week in the Journal of the American Medical Association, researchers reported a 15 percent increase in alcohol abstinence for individuals prescribed a drug commonly known as Topamax compared to those taking a placebo. Yet FDA approval might take years.

When the study began, 371 participants, each heavy drinkers, consumed 11 alcoholic beverages per day on average. Volunteers were encouraged to stop drinking, though never required. Half of the participants were prescribed gradually increasing doses of Topamax while the other half received a placebo. At the study's conclusion, 15 percent of those receiving Topamax, as opposed to just three percent of those receiving a placebo, had quit drinking altogether for seven weeks or more.

It combines vitamins, minerals, amino acid and herb therapy formulated specifically to address detoxification, craving and dependence along with home-based hypnotherapy sessions, light exercise and Topamax or other anti-craving drug administration.
"Topamax, along with several other medications, including Naltrexone, Campral, Baclofen and Acomplia, have provided much-needed relief for problem drinkers and early-stage alcoholics," states Roberta Jewell, author of the book My Way Out and owner of the highest trafficked alternative recovery website on the Internet, MyWayOut.org (stats courtesy Alexa.com).

"The My Way Out program incorporated Topamax two years ago as part of a popular, multi-faceted treatment plan," says Jewell. "It combines vitamins, minerals, amino acid and herb therapy formulated specifically to address detoxification, craving and dependence along with home-based hypnotherapy sessions, light exercise and Topamax or other anti-craving drug administration."

The latest research further reinforces the findings in the report "Oral topiramate for treatment of alcohol dependence: a randomized controlled trial" conducted by Bankole A. Johnson et al and published in The Lancet on May 17, 2003. Dr. Johnson's study found that up to 300 mg of Topamax per day was more effective than a placebo as an adjunct to standardized medication compliance management in the treatment of alcohol dependence. Johnson has expressed support for the My Way Out program when administered in conjunction with professional medical guidance and supervision.

To learn more about My Way Out, visit MyWayOut.org.

About My Way Out
My Way Out, Patent Pending, was founded in 2003 by Roberta Jewell, a pen name, to provide a multi-faceted solution for the control of early-stage alcoholism and problem drinking. The program is considered an alternative or supplemental approach to Alcoholics Anonymous and other 12-step programs. Contrary to these programs, My Way Out is administered in a private environment.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/WmV0YS1DcmFzLVN1bW0tVGhpci1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Kellie Hyder
Capalo Press
907-322-7105
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright